Why did CTOR's Q1 earnings deviate from forecasts?
4/8/2025 07:27pm
Citius Oncology, Inc. (CTOR) experienced a revenue surprise of $0 and an EPS surprise of -$0.03 for the latest report period ending on December 31, 2024. The company's Q1 earnings did not deviate significantly from forecasts, with both the revenue and EPS surprises being zero. This indicates that the actual performance was in line with the expectations.